News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,857 Results
Type
Article (13692)
Company Profile (100)
Press Release (250065)
Section
Business (88001)
Career Advice (464)
Deals (15338)
Drug Delivery (65)
Drug Development (36572)
Employer Resources (49)
FDA (6278)
Job Trends (6193)
News (150134)
Policy (14021)
Tag
Academia (437)
Alliances (23195)
Alzheimer's disease (375)
Approvals (6301)
Artificial intelligence (86)
Bankruptcy (146)
Best Places to Work (4370)
Breast cancer (69)
Cancer (501)
Cardiovascular disease (52)
Career advice (406)
Cell therapy (72)
Clinical research (30724)
Collaboration (273)
Compensation (114)
COVID-19 (753)
C-suite (90)
Data (497)
Diabetes (66)
Diagnostics (1308)
Drug discovery (46)
Drug pricing (60)
Earnings (31773)
Events (37162)
Executive appointments (309)
FDA (6593)
Funding (171)
Gene therapy (83)
GLP-1 (319)
Government (1278)
Healthcare (3551)
Infectious disease (780)
Inflammatory bowel disease (52)
Interviews (58)
IPO (5868)
Job creations (2050)
Job search strategy (372)
Layoffs (175)
Legal (3426)
Lung cancer (71)
Manufacturing (122)
Medical device (1268)
Medtech (1270)
Mergers & acquisitions (9610)
Metabolic disorders (209)
Neuroscience (519)
NextGen: Class of 2025 (1585)
Non-profit (592)
Northern California (600)
Obesity (121)
Opinion (116)
Patents (86)
People (28740)
Pharmaceutical (64)
Phase I (7997)
Phase II (12997)
Phase III (11663)
Pipeline (272)
Policy (52)
Postmarket research (1401)
Preclinical (3187)
Radiopharmaceuticals (117)
Rare diseases (141)
Real estate (2632)
Regulatory (9991)
Research institute (563)
Resumes & cover letters (55)
Southern California (594)
Startups (1625)
United States (5947)
Vaccines (132)
Weight loss (87)
Date
Today (58)
Last 7 days (252)
Last 30 days (1083)
Last 365 days (12410)
2025 (1719)
2024 (12499)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19994)
Australia (2588)
California (1431)
Canada (790)
China (185)
Colorado (60)
Connecticut (61)
Europe (39149)
Florida (250)
Illinois (165)
Indiana (113)
Japan (72)
Kansas (53)
Maryland (212)
Massachusetts (1214)
Minnesota (78)
New Jersey (608)
New York (404)
North Carolina (340)
Northern California (600)
Pennsylvania (360)
South America (500)
Southern California (594)
Texas (185)
Virginia (57)
Washington State (99)
263,857 Results for "phathom pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
·
1 min read
FDA
Phathom Scores Non-Erosive GERD Approval for Heartburn Drug
Already approved for erosive gastroesophageal reflux disease, Phathom’s Voquenza is now authorized to treat patients with non-erosive GERD.
July 18, 2024
·
1 min read
·
Kate Goodwin
Pharm Country
Phathom Pharmaceuticals to Participate in Upcoming June 2024 Investor Conferences
Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that members of its management team are scheduled to participate in the following investor conferences in June.
May 28, 2024
·
1 min read
Press Releases
Phathom Pharmaceuticals to Participate in Upcoming November 2024 Investor Conferences
November 5, 2024
·
2 min read
Business
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, reported financial results for the first quarter of 2024, and provided recent business highlights.
May 9, 2024
·
13 min read
Press Releases
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 7, 2024
·
14 min read
Pharm Country
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
Phathom Pharmaceuticals, Inc. today announced that the company will present data from multiple studies for its first-in-class treatment VOQUEZNA® (vonoprazan) including an oral presentation at Digestive Disease Week® (DDW) 2024, being held May 18-21 in Washington, D.C.
May 15, 2024
·
14 min read
Pharm Country
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Phathom Pharmaceuticals, Inc. announced today that members of the management team will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 9:30 a.m. ET.
April 3, 2024
·
1 min read
Press Releases
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
October 28, 2024
·
19 min read
Business
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update.
March 7, 2024
·
15 min read
1 of 26,386
Next
